Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 55, 116595
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell LinesMolecules, 2013
- Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and FutureThe American Journal of Chinese Medicine, 2012
- Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive componentsChinese Medicine, 2011
- Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cellsAnti-Cancer Drugs, 2010
- Anti‐Proliferative Effects of Evodiamine on Human Thyroid Cancer Cell Line AROJournal of Cellular Biochemistry, 2010
- Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I ActivityMolecules, 2009
- Progress in the Studies on RutaecarpineMolecules, 2008
- Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosisFree Radical Research, 2007
- Bcl-2 and the ICE family of apoptotic regulators: making a connectionCurrent Opinion in Genetics & Development, 1997
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966